Echocardiographic Changes in Patients with End-Stage Renal Disease at Initiation of Dialysis

Main Article Content

Shabana Nazneen
Muzamil Latief
Manjusha Yadla

Keywords

Echocardiography, Hypertension, CKD

Abstract

Introduction: Echocardiography is a simple and established method of evaluating cardiac functions, assessing left ventricle geometry, and systolic and diastolic functions. Patients with chronic kidney disease have a tremendous burden of cardiovascular disease (CVD), and patients with end-stage renal disease (ESRD) are at a greater risk of CVD and deaths.
Materials and Methods: In this study, 245 incident dialysis patients were included, and none of the patient was on erythropoietin. All the patients were aged >18 years. Patients with ESRD, already on maintenance dialysis, were not included in this study. Patient’s data such as demographic details, comorbidities, laboratory values, echocardiographic changes, management, and outcome were recorded.
Results: Out of 245 patients, 165 (67.3%) were males and 80 (32.6%) females. The mean age of the patients was 49.7 years. Left ventricular hypertrophy (LVH) was observed in 188 (76.7%), mild left ventricular dysfunction (LVD) in 25.7%, moderate LVD in 23.67%, severe LVD in 8.5%, global hypokinesia in 33.8%, valvular heart disease in 26.5%, regional wall motion abnormality in 4.4%, and pericardial effusion in 1.6% patients. Echocardiographic changes, such as LVD, LVH, and global hypokinesia, were observed in greater number in hypertensive group com-pared to normotensive group (P < 0.05). On regression analysis adjusted for age and gender, we found that hypertension and anemia (<10 g/dL) were associated with LVH. Further, hypertension and anemia (Hb < 10 g/dL) were associated with LVD. Similarly, anemia (Hb < 10 g/dL) was associated with global hypokinesia and valvular heart disease. LVD was associated with death in our study.
Conclusion: Echocardiography is a noninvasive diagnostic test which detects early changes in cardiac parameters. All ESRD patients with hypertension and anemia at the time of initiation of renal replacement therapy must undergo echocardiography screening.

Downloads

Download data is not yet available.
Abstract 54 | PDF Downloads 17 XML Downloads 4 HTML Downloads 0

References

1. Bansal N, Keane M, Delafontaine P, Dries D, Foster E, Gadegbeku CA, et al. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar;8(3):355–62. https://doi.org/10.2215/CJN.06020612
2. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998 Sep 17;339(12):799–805. https://doi.org/10.1056/NEJM199809173391203
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 Sep 23;351(13):1296–305. https://doi.org/10.1056/NEJMoa041031. Erratum in: N Engl J Med. 2008;18(4):4. PMID: 15385656.
4. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000 Jul 8;356(9224):147–152. https://doi.org/10.1016/S0140-6736(00)02456-9
5. Singh Shivendra, Doley PK, Pragya P, Sivasankar M, Singh VP, Singh Neelam. Echocardiographic changes in pts with ESRD on MHD-A single center study. J Cardiovasc Dis Diagn. 2014; 2:4. https://doi.org/10.4172/2329-9517.1000165
6. Yamada S, Ishii H, Takahashi H, Aoyama T, Morita Y, Kasuga  H, et al. Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol. 2010 Oct;5(10):1793–1798. https://doi.org/10.2215/CJN.00050110. Epub 2010 Jul 1.
7. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S112–S119. https://doi.org/10.1053/ ajkd.1998.v32.pm9820470
8. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996 Jul;11(7):1277–1285. https://doi.org/10.1093/ndt/11.7.1277
9. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, et al. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol. 2004 Apr;15(4):1029–1037. https://doi.org/10.1097/01.asn.0000117977.14912.91
10. Laddha M, Sachdeva V, Diggikar PM, Satpathy PK, Kakrani AL. Echocardiographic assessment of cardiac dysfunc-tion in patients of end stage renal disease on haemodialysis. J Assoc Physicians India. 2014 Jan;62(1):28–32. PMID: 25327089.
11. Datta S, Abraham G, Mathew M, Somasundaram H, Muralidharan TR, Moorthy A, et al. Correlation of anemia, secondary hyperparathyroidism with left ventricular hyper-trophy in chronic kidney disease patients. J Assoc Phys India (JAPI). 2006 Sep;54:699–703. PMID: 17212016.